FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib

Gao, LX; Wang, XL; Tang, YL; Huang, S; Hu, CAA; Teng, Y

Teng, Y (reprint author), Augusta Univ, Dept Oral Biol, Dent Coll Georgia, 1120 15th St, Augusta, GA 30912 USA.; Teng, Y (reprint author), Augusta Univ, Dept Biochem & Mol Biol, Med Coll Georgia, 1120 15th St, Augusta, GA 30912 USA.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017; 36 ( ):

Abstract

Background: Sorafenib, a multi-kinase inhibitor, is used as a standard therapy for advanced hepatocellular carcinoma (HCC). However, complete remissio......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索